Checkpoint Inhibitors and T Cell Therapies
An overview of the use of monoclonal antibodies (mAbs) for the treatment of certain cancers/tumours.
Monoclonal antibodies (mAbs) can be used in combination with other cancer treatments, such as chemotherapy, radiation therapy, and certain advanced therapies.
The use of mAbs as checkpoint inhibitors to enhance the clinical outcomes.
Introduction to T Cell therapies - CAR T Cell and TCR Therapies